Tag: Prescription Drugs
Maternal Asthma Rx Linked to Adverse Perinatal Outcomes
Discontinuing asthma medications in pregnancy associated with increased odds of birth at <37 and <32 weeks of gestation
Adding Baricitinib Speeds Recovery for COVID-19 Pneumonia
Odds of improvement in clinical status at day 15 greater for baricitinib plus remdesivir versus remdesivir alone
Continuing Treatment Not Beneficial After Five Years of Bisphosphonates
No difference seen in cumulative incidence of hip fracture for continuing therapy for two, five additional years versus discontinuing
ASH: Adding Subcutaneous Daratumumab Slows Advanced Multiple Myeloma
Subcutaneous daratumumab plus pomalidomide and dexamethasone reduces risk of progression, death in relapsed/refractory MM
Antiviral Drugs Have No Effect on Mortality in COVID-19
Remdesivir, hydroxychloroquine, lopinavir, interferon regimens have little to no effect on in-hospital mortality
Pembrolizumab Slows MSI-H-dMMR Metastatic CRC
Pembrolizumab superior to chemo for progression-free survival among patients who had not previously received treatment
Higher Doses of Z-Drugs Pose Risks for Dementia Patients
Risks for fracture, falls, ischemic stroke increased in patients with dementia prescribed higher doses of Z-drugs
Industry Payments Consistently Linked to Physician Prescribing
Thirty of 36 studies identified a positive association between payments and prescribing in all analyses
WHO: Strawberry-Flavored HIV Medication Coming for Infants
WHO has also approved the dapivirine ring, a vaginal insert that has shown to be effective in protecting against HIV in women
Canagliflozin Beneficial Even for Advanced Kidney Disease
Canagliflozin slows progression of kidney disease in participants with eGFR <30 mL/min/1.73 m2 with no increase in AKI